In conclusion, recent studies showed that the effect of oral and inhaled PDE4 inhibitors on exacerbations in COPD patients with chronic bronchitis appears to be greater at higher blood eosinophil counts.4, 10. This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.